Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guben Kechuan Granules for cough and wheezing in pulmonary tuberculosis
ChiCTR2500104717Phase 4Not yet recruiting
- Sponsor
- Wuhan Jinyintan Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Guben Kechuan in pulmonary tuberculosis (TB) (2 arms), sponsored by Wuhan Jinyintan Hospital. Primary endpoints: Cough Symptom Scorecard (CSS), Pulmonary function (FVC, PEF, MMEF) and 1 more. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
Guben Kechuan
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2500104717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104717.